Comparison of methodological data measurement limits in CD4+ T lymphocyte flow cytometric enumeration and their clinical impact on HIV management

Cytometry Part B - Clinical Cytometry

Volumn 84, Issue 4, 2013, Pages 248-254

  Whitby, Liam ^a   Whitby, Alison ^a   Fletcher, Matthew ^a   Helbert, Matthew ^b   Reilly, John T ^a   Barnett, David ^a  

^a UK NEQAS for Leucocyte Immunophenotyping   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

CD4; flow cytometry; HIV; quality assessment; quality control; reproducibility; T lymphocytes

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL DECISION MAKING; COMPARATIVE STUDY; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MEASUREMENT PRECISION; PRIORITY JOURNAL;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOPHENOTYPING; REFERENCE STANDARDS;

EID: 84879336648     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.21094     Document Type: Article

References (16)

1. Andrew NP, Jens DL,. The CD4 lymphocyte count and risk of clinical progression. Curr Opin HIV AIDS 2006; 1: 43-49.
2. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at http://aidsinfo.nih.gov/ contentfiles/lvguidelines/AdultandAdolescentGL.pdf Section accessed 01/10/ 2012.
3. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents. Geneva: WHO, 2010.
4. Nelson M, Dockrell DH, Edwards S, on behalf of the BHIVA Guidelines Subcommittee. British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med 2011; 12 (Suppl 2): 1-5.
5. European AIDS Clinical Society. Guidelines. Version 6- October 2011.
6. Higgins J, Hill V, Lau K, Simpson V, Roayaei J, Klabansky R, Stevens RA, Metcalf JA, Baseler M,. Evaluation of a single platform technology for lymphocyte immunophenotyping. Clin Vaccine Immunol 2007; 14: 1342-1348.
7. Barnett D, Granger V, Whitby L, Storie I, Reilly JT,. Absolute CD4+ T-Lymphocyte and CD34+ stem cell counts by single platform flow cytometry: The way forward. BJH 1999; 106: 1059-1062.
8. Robinson G, Morgan L, Evans M, McDermott S, Pereira S, Wansbrough-Jones M, Griffin G,. Effect of type of haematology analyser on CD4 count. Lancet 1992; 340: 485.
9. Connelly MC, Knight M, Giorgi JV, Kagan J, Landay AL, Parker JW, Page E, Spino C, Wilkening C, Mercolino TJ,. Standardization of absolute CD4+ lymphocyte counts across laboratories: An evaluation of the ortho CytoronAbsolute flow cytometry system on normal donors. Cytometry 1995; 22: 200-210.
10. Schnizlein-Bick CT, Spritzler J, Wilkening CL, Nicholson JKA, O'Gorman MRG,. Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus positive adults. Clin Diagn Lab Immunol 2000; 7: 336-343.
11. Reimann KA, O'Gorman MRG, Spritzler J, Wilkening CL, Sabath DE, Helm K, Campbell DE,. Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: Evaluation of Beckman Coulter flow-count fluorosperes and the tetraONE system. Clin Diagn Lab Immunol 2000; 7: 344-351.
12. Kunkl A, Risso D, Terranova MP, Girotto M, Brando B, Mortara L, Lantieri PB,. Grading of laboratories on CD4+ T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement error. Cytometry 2002; 50: 117-126.
13. Barnett D, Granger V, Mayr P, Storie I, Wilson GA, Reilly JT,. Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: Results from the UK NEQAS immune monitoring scheme. Cytomtery 1996; 26: 216-222.
14. Whitby L, Granger V, Storie I, Goodfellow K, Sawle A, Reilly JT, Barnett D,. Quality control of CD4+ T-lymphocyte enumeration: Results from the last 9 years of the United Kingdom national external quality assessment scheme for immune monitoring (1993-2001). Cytometry 2002; 50: 102-110.
15. Healy MJR,. Outliers in clinical chemistry quality control schemes. Clin Chem 1979; 25: 675-677.
16. Barnett D, Granger V, Kraan J, Whitby L, Reilly JT, Papa S, Gratama JW,. Reduction of intra- and interlaboratory variation in CD34 stem cell enumeration by the use of stable test material, standard protocols and targeted training. Br J Haematol 2000; 108: 784-792.